# Venky Soundararajan

> Venky Soundararajan is a Cambridge-based biological engineer, inventor and company builder who co-founded nference to make fragmented biomedical information computable. Trained at IIT Guwahati, MIT and Harvard Medical School, he has extended that thesis from clinical records into AI-interpreted ECGs through Anumana and digital pathology through Pramana, while helping build long-term research partnerships with major health systems.

- **Role:** Co-Founder and Chief Scientific Officer at nference
- **Organizations:** nference, Anumana, Pramana, Qrativ, Mayo Clinic, Massachusetts Institute of Technology, Harvard Medical School
- **Education:** Bachelor of Technology in Electronics and Communication Engineering, Indian Institute of Technology Guwahati, PhD in Biological Engineering, Massachusetts Institute of Technology, Research Fellowship in Genetics, Harvard Medical School
- **Known for:** Co-founded nference and helped establish its long-term strategic partnership with Mayo Clinic., Co-founded Anumana and Pramana, extending a common biomedical-computing thesis into ECG analysis and digital pathology., Authored or co-authored more than 50 scientific papers and patents, according to his official nference biography.

## Career timeline

- **2005-2010** — Conducted biological engineering research at MIT while completing his PhD.
- **2011** — Received an MIT Outstanding Undergraduate Student Mentor Award.
- **2013** — Co-founded nference with Murali Aravamudan around a platform for synthesizing and triangulating unstructured biomedical data.
- **2017** — Became co-founder and chief scientific officer of Qrativ, the Mayo Clinic-nference joint venture for drug discovery and development.
- **2018** — Named to the MedTech Boston 40 Under 40 Healthcare Innovators list.
- **2021** — Co-founded Anumana to develop AI applications from electrophysiology signals.
- **2022** — Became founder and chief scientific officer of Pramana, focused on digital pathology infrastructure.
- **2025** — Discussed nference's multimodal precision-medicine work in an interview recorded at the New York Stock Exchange.
- **2026** — Led and co-authored work from nference's Metabolism Agentic Intelligence Atlas and helped announce a long-term federated research collaboration with Rush University System for Health.

## Achievements

- Co-founded nference and helped establish its long-term strategic partnership with Mayo Clinic.
- Co-founded Anumana and Pramana, extending a common biomedical-computing thesis into ECG analysis and digital pathology.
- Authored or co-authored more than 50 scientific papers and patents, according to his official nference biography.
- Contributed to research spanning protein networks, genome editing, biomedical knowledge synthesis and real-world clinical evidence.
- Received the MIT Outstanding Undergraduate Student Mentor Award in 2011.
- Was named a 2018 MedTech Boston 40 Under 40 Healthcare Innovator.

## Latest updates

- **2026-09** — nference and Rush University System for Health announced a long-term collaboration to build a secure, Rush-hosted platform for research on de-identified longitudinal and multimodal clinical data.
- **2026-08** — Soundararajan discussed the limits of retrospective real-world evidence and the further evidence needed before findings should influence prescribing in an interview with Contagion.
- **2026-06** — nference announced the first series of studies from its Metabolism Agentic Intelligence Atlas, drawing on a federated network of more than 30 million de-identified patient records.
- **2025-03** — Valo Health and nference announced a multi-year collaboration combining federated real-world data with Valo's computational drug-discovery platform.

## Links

- Website: https://nference.com
- LinkedIn: https://www.linkedin.com/in/venkysoundararajan
- Twitter/X: https://twitter.com/_nference
- Facebook: https://facebook.com/nferencelabs/

---

Profile page: https://yespress.io/venky-soundararajan
Published by YesPress — https://yespress.io
Last updated: 2026-09-28